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Binding of a ligand to the extracellular site of a 
membrane receptor involves conformational changes 
not only of the extracellular nd cytoplasmic sites but 
also of the membrane-spanning se ments of the re- 
ceptor protein. The lipids forming the environment of 
the trans-membrane receptor segments, being flexible 
and mobile, must follow the shape changes of the re- 
ceptor molecule to some extent. For this reason ligand- 
receptor binding itself can be expected to result in 
changes of the packing of lipid molecules surrounding 
the receptor. Since lipids are organized in a cooperative 
manner such changes may affect large areas of the 
membrane and hence can be registered by physical 
methods. It has been stated repeatedly that binding of 
various ligands including hormones, antibodies or 
lectins to membrane-associated receptors is ac- 
companied by fluidity changes of the target membrane 
[1-3]. 
The aim of this article is to summarize r cent evidence 
suggesting that in highly heterogeneous biological 
membranes containing numerous metastable lipid 
domains and/or clusters conformational changes of 
membrane- associated proteins may result not only in 
global fluidity changes but also in alterations of the 
supramolecular lipid domain organization. Frequently 
such changes can be tbllowed by using, as fluorescent 
probe, analogs of natural membrane phospholipids or 
glycolipids bearing, at the end of one of the fatty acyl 
chains, a 9.anthrylvinyl (AV) group (Fig. 1) (reviewed 
in [4,5]). These fluorescent lipid probes were shown to 
report ruly on the phase behavior of their natural pro- 
totypes with the same headgroup [6]. They incorporate 
spontaneously into membrane preparations and intact 
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cells, and in the latter case may reside for a relatively 
long time in the plasma membrane without internaliza- 
tion [7]. 
In comparison to most other fluorophores used in 
membrane research, the AV group displays important 
advantages. It causes little disturbance because it is non- 
polar, flat, and relatively compact. When attached to 
the fatty acyl chain at an appropriate distance from the 
head group the AV-fluorophores reside uniformly and 
exclusively in the center of the bilayer where the host 
lipids are packed most loosely, and affect neither the 
mobility nor the orientation and conformation of the 
major part of the molecules of the surrounding host 
lipids including their head groups [8]. The AV-group is 
characterized also by high quantum yields and very 
short fluorescence lifetimes [9]. The latter property 
makes the AV-fluorophore suitable for fluorescence po- 
larization measurements. Moreover, in phospholipid 
bilayers the restricted rotational diffusion of the AV- 
labeled lipid molecules i of the same time scale as the 
fluorescence d cay. Therefore ven subtle changes in the 
fluidity of the probes microenvironment produce con- 
siderable changes in the polarization of fluorescence. 
The fluorescent parameters of the AV-group ( ,~  365 
nm, A,~m 430 rim; high extinction coefficient) make it also 
a highly efficient acceptor for resonance energy transfer 
(RET) from nearby tryptophans. Since the distance that 
RET can occur over is as long as 5 nm while RET 
efficiency depends on the sixth power of the donor- 
acceptor distance, RET measurements with AV-labeled 
lipids permits the following of even extremely small 
changes in the relative localization of proteins and 
lipids. 
When located in the same environment, AV-labeled 
phospho!ipids with different head groups show very 
similar fluoroscence parameters. However, in hete- 
rogeneous lipid matrixes where macro- or microscopic 
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Fig. l, Antbrylvinyl-lab¢lcd phospholipids, 
phase seggrcgations are possible, these values may 
differ significantly because the AV-labeled lipids tend to 
partition between different domains localizing predo- 
minantly together with their natural prototypes having 
the same head group [5,6]. Accordingly we suggested 
the following approach to visualize changes in lipid 
domain organization [5]. Membranes or cells are 
labeled separately with two or more AV-lipids identical 
or very similar in all aspects except the polar head 
groups. Substantial differences in the probes fluorescent 
parameters suggest that the host lipids distribute non- 
randomly in the membrane and that the various AV- 
lipids probe different domains with a certain selectivity. 
If in such systems different probes respond ifferently 
to an extrinsic stimulus (e,g. to binding of a ligand), this 
indicates that the fluidity of various domains probed by 
the AV-lipids has changed ifferentially, i.e. that some 
rearrangement of the lipid matrix must have taken 
place. By this 'multi probe approach' any disturbance 
induced by the probes themselves i thus largely re- 
moved. 
The possibility of using AV-labeled phospolipids to 
monitor specific ligand-receptor binding was first tested 
with a simple model, the interaction of the binding unit 
of the plant oxin ricin (Re) with Burkitt lymphoma cells 
doped with AV-labeled sphingomyelin (ASM) or phos- 
phatidylcholine (APC) [10]. The peptid¢ Re is known to 
bind to any glycoprotein or glycolipid having an acces- 
sible terminal galactose. The fluorescence polarization 
changes induced by binding of ga to the cells prclabeled 
with ASM or APC (Fig. 2) proved to be specific and 
reversible because they were abolished by excess 
galactose (but not by glucose) and because the toxic 
subunit of ricin, Re, which is known to bind in an 
unspecific manner, did not induce any response. The 
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Fig. 2, Changes in fluorescence polarization of ASM-labeled Burkitt 
lymphoma cells induced by the binding subunit of ri¢in (Re). z lP -  Po, 
where P and Po are values of the fluorescence anisotropy before and 
after addition of Ca. 
strikingly high. The lowest Re concentration detectable 
by the fluorescence method was 10 -ti M, which cor- 
responds to a few Ra molecules per cell. Remarkably, 
the fluorescence polarization values of anthrylvinyl- 
labeled phosphatidylcholine and sphingomyelin shifted 
in different directions upon binding of Re. This lends 
additional support o the supposition that ligand-re- 
ceptor binding may be accompanied by a reorganiza- 
tion of the supramolecular domain structure of the 
lipids surrounding the receptor. At the same time no 
significant changes could be observed when using di- 
phenylhexatriene as a probe, presumably because the 
latter distributes less specifically between different lipid 
domains. 
The ricin-induced fluorescence polarization changes 
of the lipid probe ASM were concentration-dependent, 
saturable and followed simple Michaelis--Menten kinetics 
(Fig. 2). In an attempt to derive the association constant 
from fluorescence polarization changes we assumed 
that the latter are proportional to the number of 
occupied binding sites. If that assumption is true the 
corresponding Hill plot should have a linear regression. 
This was indeed found to be the case for low con- 
ccntrations of RD. The apparent/(0 obtained from the 
fluorescence polarization data was in reasonable agree- 
ment with that derived from radioligand measurements 
using mI-labded Re [10]. However, the latter method 
revealed the presence of an additional binding site of 
lower affinity which was not sensed by the fluorescent 
lipid probes. Neither did the anthrylvinyl labeled lipids 
respond to binding of Re to glycolipids present on the 
cell surface [11]. It thus appears that while binding of 
the peptide to its proteinaceous receptor induces notice- 
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able changes in the domain organization of  surrounding 
lipids, binding of the same ligand to glycolipids is not 
able to initiate such changes. 
In the same manner fluidity changes of the lipid en- 
vironment were detected after addition of  specific mus- 
carinic ligands to rat brain membrane fragments (Fig. 
3) [12] prelabeled with APC. In these experiments he 
muscarinic agonist, carbachol, and the antagonist, 
atropine, appeared to compete for the same receptor; 
however, the maximal effect of atropine was consid- 
erably smaller. Apparantly agonist binding to the re- 
ceptor resulted in a more significant conformational 
change ofthe protein that caused larger earrangements 
in the membrane lipid structure. 
The fluidization effect caused by binding ofcarbachol 
or atropine to the muscarinic receptor followed a simple 
binding isotherm (Fig. 3). Treatment of these experi- 
mental data according to the Hill equation yielded 
linear dependencies. The apparent KD values obtained 
in this way were 3 pM for atropine and 5 pM for car- 
bachol. The low value of the Hill coefficent, Nn = 0.54, 
for carbachol pointed to the presence of heterogeneous 
binding sites or to negative cooperativity of the binding 
process. 
The picomolar/¢D values obtained in the above study 
were in marked contrast o the micromolar constants 
obtained by measurement of tissue responses to musea- 
rinic stimulation (see [13-15] for some recent ref- 
erences). Certainly° this is not surprizing since one could 
hardly expect a direct interrelation between ligand-in- 
duced fluidity changes at 25°C and biochemical or phy- 
siological responses at 37°C. 
We also attempted to use the fluorescent lipid probes 
to study the binding of cells to antibodies [16]. When 
poly- or monoclonal antibodies, raised against he light 
chains of human Ig, were added to Burkitt lymphoma 
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Fig. 4. Dependence of fuorescence polarization changes of ASM- 
labeled Burkitt lymphoma cells on the concentration of poly- and 
monoelonal antibodies against he L.chain of haman 1~; AP = P-P , , ,  
where P and Po arc fluorescence polarization values in the presence 
or absence of antibody. 
cells prelabeled with ASM, binding of even a few anti- 
body molecules clearly could be detected by fluores- 
cence polarization changes (Fig. 4) of the lipid probe, 
although the dissociation constants differed substan- 
tially from those derived from radioligand studies with 
iodinated antibodies. 
In a similar way it was shown that binding of prosta- 
glandins to erythrocytes or of platelet activation factor 
(PAF) to platelets prelabeled with AV-lipid probes, re- 
suited in lipid rearrangements detectable by changes in 
the fluorescence polarization of the probes [17,18]. In 
both cases the response appeared to be specific (the 
effects ofprostaglandin E1 and PAF were not paralleled 
by prostaglandin E2 and chemically modified non-ac- 
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i "~ O FiR. 3. (A) Changes in fluorescence polarization of APC-labeled rat brain membranes alter addition of muscarinic l!gands at .5 C. (B) Hill plots 
of effects of muscarinic ligands on the fluorescence polarization. AP = P - Po, where P and Po are fluorescence polarize,ion values before and 
after addition of the Iigands. 
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tive PAF analogs, respectively) and extremely sensitive: 
even a few ligand molecules per cell induced measurable 
changes in the P-values of the AV-labeled lipid probes. 
Here again, AV-labeled lipids with different polar head 
groups proved to respond differently to one and the 
same ligand, indicative of rearrangements of lipid 
domain organization in response to ligand-receptor in- 
teraction. 
Summarizing, it can be said that the results of flu- 
orescent lipid-based binding assays may or may not 
coincide quantitatively with those of radioligand and 
other studies. Nevertheless the fluorescence method has 
at least two merits. First, it appears to be much more 
sensitive than traditional radioligand measurements be- 
cause it takes advantage of the fact that conformational 
changes of one receptor molecule can be transferred to 
large numbers of lipids organized in a cooperative 
manner. Second, one observes apparently only specific 
interactions. Besides this, the fluorescence method is 
fast, simple and requires no prelabeling of the Iigand or 
the receptor. It thus may become an additional tool in 
certain areas of receptor research, e.g. in studies of 
drug- agonists and antagonists competition. A more 
general and highly provocative question posed by the 
above findings is whether reorganizations of the lipid 
matrix induced by ligand-receptor binding are able to 
influence functional activities of the membrane and to 
trigger biochemical events inside the cell. This problem 
appears to deserve further investigation. 
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